Because our goal was to test if these are still effective in the context of additional oncogenic alterations, we did not assess all possible combinations, and instead, focused on testing of a control and the Rbf1 RNAi, Pten RNAi, Ras1A-OE tumor model. Here, PTEN is linked to neoplasm.